CR9053A - Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia - Google Patents

Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia

Info

Publication number
CR9053A
CR9053A CR9053A CR9053A CR9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A
Authority
CR
Costa Rica
Prior art keywords
phenyl
group
epilepsy
alkyl
ethanodiol
Prior art date
Application number
CR9053A
Other languages
English (en)
Inventor
Yong Moon Choi
Robert Gordon
Gerald P Novak
Carlos R Plata-Salaman
Roy E Twyman
H Steve White
Boyu Zhao
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR9053A publication Critical patent/CR9053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion se refiere a metodos para prevenir, tratar, revertir, inhibir o detener la epilepsia y epiletogenesis en un sujeto, que comprende administrar al sujeto en necesidad del mismo una cantidad terapeuticamente efectiva de un compuesto seleccionado del grupo que consiste en la formula (I) y formula (II), o un sal o ester farmaceuticamente aceptable del mismo.
CR9053A 2004-09-16 2007-04-13 Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia CR9053A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61027604P 2004-09-16 2004-09-16
US69862505P 2005-07-12 2005-07-12
US70724205P 2005-08-11 2005-08-11

Publications (1)

Publication Number Publication Date
CR9053A true CR9053A (es) 2009-10-30

Family

ID=36087909

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9053A CR9053A (es) 2004-09-16 2007-04-13 Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia

Country Status (23)

Country Link
US (2) US20060194873A1 (es)
JP (1) JP2008513466A (es)
KR (1) KR20070057939A (es)
CN (1) CN101056629B (es)
AT (1) ATE464044T1 (es)
AU (1) AU2005287174B2 (es)
BR (1) BRPI0515374A (es)
CA (1) CA2580640A1 (es)
CO (1) CO6382111A2 (es)
CR (1) CR9053A (es)
DE (1) DE602005020667D1 (es)
DK (1) DK1809273T3 (es)
EA (1) EA200700642A1 (es)
ES (1) ES2342185T3 (es)
HK (1) HK1105583A1 (es)
HR (1) HRP20100304T1 (es)
IL (1) IL181910A0 (es)
MX (1) MX2007003278A (es)
NO (1) NO20071921L (es)
NZ (1) NZ553813A (es)
PT (1) PT1809273E (es)
RS (1) RS51269B (es)
WO (1) WO2006033947A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378955A1 (en) * 1999-08-10 2001-02-15 Uab Research Foundation Use of gaba agonists for treatment of spastic disorders, convulsions, and epilepsy
BRPI0516112A (pt) * 2004-10-15 2008-08-26 Janssen Pharmaceutica Nv métodos para neuroproteção
PE20070325A1 (es) * 2005-06-29 2007-05-12 Alza Corp Formas de dosificacion oral que comprenden compuestos derivados de carbamato
US20070021500A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods for neuroprotection
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
KR101518427B1 (ko) 2006-06-15 2015-05-08 유씨비 파르마 게엠베하 상승적 항경련 효과를 갖는 약제학적 조성물
MX2009003755A (es) * 2006-10-06 2009-07-10 Janssen Pharmaceutica Nv Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato.
JP2010508354A (ja) * 2006-10-31 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 広汎性発達障害の処置
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2013100568A1 (en) 2011-12-27 2013-07-04 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating stroke
EP2970111A4 (en) * 2013-03-12 2017-01-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
WO2014142477A1 (en) 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
JP6807941B2 (ja) * 2016-02-29 2021-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド スルファメート誘導体化合物、その製造方法および用途
CN106053510A (zh) * 2016-05-16 2016-10-26 山东省分析测试中心 一种基于氢核磁共振快速测定普瑞巴林原料药纯度的方法
KR102421006B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU3304997A (en) * 1996-05-31 1998-01-05 Southern Illinois University Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
WO2000047202A1 (en) * 1999-02-09 2000-08-17 University Of Virginia Patent Foundation Felbamate derived compounds
DE60038738T2 (de) * 1999-07-26 2009-07-02 Sk Holdings Co., Ltd. Transnasale anticonvulsive zusammensetzungen
KR20030074849A (ko) * 2001-02-27 2003-09-19 오르토-맥네일 파마슈티칼, 인코퍼레이티드 양극성 장애의 예방 또는 치료에 사용하기 위한카바메이트 화합물
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
PL364638A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder

Also Published As

Publication number Publication date
BRPI0515374A (pt) 2008-07-22
WO2006033947A3 (en) 2006-06-29
DE602005020667D1 (de) 2010-05-27
HRP20100304T1 (hr) 2010-09-30
ES2342185T3 (es) 2010-07-02
CO6382111A2 (es) 2012-02-15
DK1809273T3 (da) 2010-08-02
AU2005287174A1 (en) 2006-03-30
RS51269B (sr) 2010-12-31
NO20071921L (no) 2007-06-12
ATE464044T1 (de) 2010-04-15
KR20070057939A (ko) 2007-06-07
US20060194873A1 (en) 2006-08-31
JP2008513466A (ja) 2008-05-01
HK1105583A1 (en) 2008-02-22
US20110152362A1 (en) 2011-06-23
EA200700642A1 (ru) 2007-10-26
CA2580640A1 (en) 2006-03-30
WO2006033947A2 (en) 2006-03-30
NZ553813A (en) 2010-09-30
AU2005287174B2 (en) 2012-01-12
CN101056629A (zh) 2007-10-17
IL181910A0 (en) 2007-07-04
MX2007003278A (es) 2007-10-08
CN101056629B (zh) 2012-01-11
PT1809273E (pt) 2010-05-10

Similar Documents

Publication Publication Date Title
CO6382111A2 (es) Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia
WO2007008562A3 (en) Carbamate compounds for use in treating neurodegenerative disorders
TW200744575A (en) Methods of treating epileptogenesis
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
RS67603A (en) Carbamate compounds for use in the treatment of pain
MX2009004553A (es) Metodos para el tratamiento de trastornos cocleares y vestibulares.
HK1062270A1 (en) Carbamate compounds for use in preventing or treating anxiety disorders
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
TW200701978A (en) Methods of treating epileptogenesis and epilepsy
HK1063435A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain
CY1110672T1 (el) Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)